3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
38
Pancreatic Neoplasms
21
Stomach Neoplasms
16
Colonic Neoplasms
13
Carcinoma, Non-Small-Cell Lung
11
Burkitt Lymphoma
11
Adenocarcinoma Of Esophagus
11
Rectal Neoplasms
10
Neoplasm Metastasis
10
Esophageal Neoplasms
10
Neoplasms
9
Cholangiocarcinoma
6
Adenocarcinoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lung Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Myelodysplastic Syndromes
2
Lymphoma
2
Leukemia
2
Down Syndrome
2
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Leucovorin
×
90 days
×
Clear all
No trials found.